Additional file 1 of Description of the use of multicriteria to support pricing and reimbursement decisions by European health technology assessment bodies
Objectives: The aim of this study was to characterize the reimbursement policy for orphan drugs (ODs) in Central and Eastern European (CEE) countries in relation to the availability and impact of clin
